- The study tracked more than 105,000 women for up to 32 years
- They were 9 percent less likely to die than women who had never had HRT
- HRT replaces lost hormones when a woman goes through menopause.
Women who take hormone replacement therapy may have a reduced risk of dying early.
A study of more than 105,000 tracked for 32 years showed that they were 9 percent less likely to die, compared to women of the same age who had never had HRT.
About one in seven menopausal women in England are believed to be on HRT, which can relieve symptoms such as hot flushes, night sweats and depression.
Researchers from the University of East Anglia looked at the medical records of healthy women in the UK who began taking ‘combined’ HRT between 1984 and 2017 between the ages of 46 and 65.
The therapy, which replaces hormones lost when a woman goes through menopause, has been linked in some studies to an increased risk of breast cancer, which may affect its uptake.
Women taking hormone replacement therapy may have lower risk of dying early
But the authors of the current study say it may offer health benefits, including strengthening bones and reducing the risk of breaking them.
Broken bones in older people can increase their risk of dying after infection and complications.
Nick Steele, co-author of the study and clinical professor of public health at Norwich Medical School, said: ‘It is exciting that this new research found that combined HRT use was associated with an overall lower risk of death, and that Estrogen-only HRT was not associated with an increased risk of death.’
The unpublished results come as the Commons prepares to debate a private member’s bill this week from Labor MP Carolyn Harris to eliminate HRT prescription fees.
The cost of therapy taken by an estimated one million women is around £9 per prescription, meaning that some women who take two types of hormones pay around £100 per year.
New research found a 9 percent reduction in the risk of dying for women taking only combined HRT, which contains two hormones — estrogen and progesterone.
Estrogen-only HRT, given to women who have had a hysterectomy, did not show any significant association with the risk of dying.
The study, conducted by the Institute and the Faculty of Actuaries, found that women on combined HRT had lower rates of heart failure and type 2 diabetes than 224,643 women of the same age who did not take HRT, the authors say. It might help to explain them. low risk of death.
The strength of the study is that people on combined HRT had a reduced risk of death, regardless of factors such as their weight, high blood pressure, and smoking, and looked at a large overall patient group of approximately 330,000 women.
Haitham Hamoda, president of the British Menopause Society, said the findings sent ‘a very positive message … and provided reassurance for women considering their options during menopause’.